411 related articles for article (PubMed ID: 32760396)
1. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.
Kraaijvanger R; Janssen Bonás M; Vorselaars ADM; Veltkamp M
Front Immunol; 2020; 11():1443. PubMed ID: 32760396
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
5. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
6. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of serum markers in pulmonary sarcoidosis.
Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
[TBL] [Abstract][Full Text] [Related]
8. Conventional markers in determination of activity of sarcoidosis.
Gungor S; Ozseker F; Yalcinsoy M; Akkaya E; Can G; Eroglu H; Genc NS
Int Immunopharmacol; 2015 Mar; 25(1):174-9. PubMed ID: 25623898
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis.
Keicho N; Kitamura K; Takaku F; Yotsumoto H
Chest; 1990 Nov; 98(5):1125-9. PubMed ID: 2171882
[TBL] [Abstract][Full Text] [Related]
10. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
Gundlach E; Hoffmann MM; Prasse A; Heinzelmann S; Ness T
PLoS One; 2016; 11(1):e0147258. PubMed ID: 26799486
[TBL] [Abstract][Full Text] [Related]
12. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluating serum angiotensin-converting enzyme in sarcoidosis.
Zheng SY; Du X; Dong JZ
Front Immunol; 2023; 14():950095. PubMed ID: 37868968
[TBL] [Abstract][Full Text] [Related]
14. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis.
Ramos-Casals M; Retamozo S; Sisó-Almirall A; Pérez-Alvarez R; Pallarés L; Brito-Zerón P
Expert Rev Clin Immunol; 2019 Apr; 15(4):391-405. PubMed ID: 30632406
[TBL] [Abstract][Full Text] [Related]
15. Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
Enyedi A; Csongrádi A; Altorjay IT; Beke GL; Váradi C; Enyedi EE; Kiss DR; Bányai E; Kalina E; Kappelmayer J; Tóth A; Papp Z; Takács I; Fagyas M
Clin Chim Acta; 2020 Jan; 500():155-162. PubMed ID: 31672631
[TBL] [Abstract][Full Text] [Related]
16. A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis.
Kiko T; Yoshihisa A; Kanno Y; Yokokawa T; Abe S; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Ishida T; Takeishi Y
Int Heart J; 2018 Sep; 59(5):996-1001. PubMed ID: 30101857
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
18. [Role of biochemical markers in sarcoidosis].
Miura K; Takahashi K; Fukuchi Y
Nihon Rinsho; 2002 Sep; 60(9):1741-6. PubMed ID: 12233069
[TBL] [Abstract][Full Text] [Related]
19. SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis.
Zhou Y; Chen X; Zhao M; Lower EE; Baughman RP
Respir Res; 2023 Sep; 24(1):219. PubMed ID: 37679741
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.
Yasar Z; Özgül MA; Cetinkaya E; Kargi A; Gül Ş; Talay F; Tanriverdi E; Dincer HE
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):318-24. PubMed ID: 26847099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
